Benefit or toxicity from neurologically targeted antiretroviral therapy?

Clin Infect Dis. 2010 Mar 15;50(6):930-2. doi: 10.1086/650744.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • AIDS Dementia Complex / prevention & control*
  • Anti-HIV Agents / adverse effects*
  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active / methods*
  • Brain / drug effects*
  • Brain Chemistry
  • HIV Infections / complications*
  • HIV Infections / drug therapy*
  • Humans
  • Neuropsychological Tests

Substances

  • Anti-HIV Agents